Confluence Wealth Services’s Definium Therapeutics DFTX Stock Holding History

Confluence Wealth Services’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+4,796	New	+$119K	0.01%	445

Other funds holding DFTX

Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return

Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Confluence Wealth Services's DFTX Position: Q2 2026 in Review

Confluence Wealth Services opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 4,796 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #445 among its holdings.

45 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Confluence Wealth Services held 4,796 shares of Definium Therapeutics worth $226K as of Q2 2026.
Definium Therapeutics was a new Confluence Wealth Services position in Q2 2026.
Definium Therapeutics made up 0.01% of Confluence Wealth Services's portfolio in Q2 2026, its #445 holding.
45 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.